SMAD-Independent Down-Regulation of Caveolin-1 by TGF-β: Effects on Proliferation and Survival of Myofibroblasts
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Transforming growth factor-β (TGF-β) mediates growth-inhibitory effects on most target cells via activation of the canonical SMAD signaling pathway. This growth-inhibitory activity may be coupled with cellular differentiation. Our studies demonstrate that TGF-β1 inhibits proliferation of primary, non-transformed human lung fibroblasts in association with the induction of myofibroblast differentiation. Differentiated myofibroblasts maintain the capacity to proliferate in response to exogenous mitogenic stimuli and are resistant to serum deprivation-induced apoptosis. These proliferative and anti-apoptotic properties of myofibroblasts are related, in part, to the down-regulation of caveolin-1 (Cav-1) by TGF-β1. Cav-1 down-regulation is mediated by early activation of p38 MAPK and does not require SMAD signaling. In contrast, myofibroblast differentiation is dependent on activation of the SMAD pathway, but not on p38 MAPK. Thus, combinatorial signaling by TGF-β1 of myofibroblast differentiation and down-regulation of Cav-1 by SMAD and p38 MAPK pathways, respectively, confer proliferative and apoptosis-resistant properties to myofibroblasts. Selective targeting of this SMAD-independent, p38-MAPK/Cav-1-dependent pathway is likely to be effective in the treatment of pathological conditions characterized by TGF-β signaling and myofibroblast activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of p38 MAPK inhibitors also lowers TGFβ-induced collagen type I and αSMA production and prevents TGFβ-induced AKT signaling (53–55).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B., & Fauci, A. S. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.5.1037 · Cited by 1,582
Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice
Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., et al. (2001) · Science · doi:10.1126/science.1062688 · Cited by 1,552
Correlation of Terminal Cell Cycle Arrest of Skeletal Muscle with Induction of p21 by MyoD
Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., & Lassar, A. B. (1995) · Science · doi:10.1126/science.7863327 · Cited by 1,149
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Caveolae: From Cell Biology to Animal Physiology
Razani, B., Woodman, S. E., & Lisanti, M. P. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.431 · Cited by 987
Mechanisms of Pulmonary Fibrosis
Thannickal, V. J., Toews, G. B., White, E. S., Lynch III, J. P., & Martinez, F. J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103810 · Cited by 808
Self-citationGrowth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth Factor
Tucker, R. F., Shipley, G. D., Moses, H. L., & Holley, R. W. (1984) · Science · doi:10.1126/science.6093254 · Cited by 768
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
Kehrl, J. H., Roberts, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B., & Fauci, A. S. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.12.3855 · Cited by 759
Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., & Ross, R. (1990) · Cell · doi:10.1016/0092-8674(90)90448-n · Cited by 741
TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses
Yu, L. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf366 · Cited by 721
Lu, Z., Ghosh, S., Wang, Z., & Hunter, T. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00304-0 · Cited by 647
Thannickal, V. J., Lee, D. Y., White, E. S., Cui, Z., Larios, J. M., Chacon, R., Horowitz, J. C., Day, R. M., & Thomas, P. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208544200 · Cited by 609
Self-citationDe novo formation of caveolae in lymphocytes by expression of VIP21-caveolin.
Fra, A. M., Williamson, E., Simons, K., & Parton, R. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8655 · Cited by 596
The stroma reaction myofibroblast: a key player in the control of tumor cell behavior
Desmouliere, A., Guyot, C., & Gabbiani, G. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041802ad · Cited by 551
Leof, E. B., Proper, J. A., Goustin, A. S., Shipley, G. D., DiCorleto, P. E., & Moses, H. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2453 · Cited by 529
Caveolin-1 in oncogenic transformation, cancer, and metastasis
Williams, T. M., & Lisanti, M. P. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00458.2004 · Cited by 511
Galbiati, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6633 · Cited by 471
Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
Wang, X. M., Zhang, Y., Kim, H. P., Zhou, Z., Feghali-Bostwick, C. A., Liu, F., Ifedigbo, E., Xu, X., Oury, T. D., Kaminski, N., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061536 · Cited by 397 · cited 1×
“Our study is similar to another report that TGF-β1 mediates the down-regulation of Cav-1 in human lung fibroblasts [44,45] and studies showed the decreased Cav-1 in IPF fibroblasts [44,45].”
ResultNabel, E. G., Shum, L., Pompili, V. J., Yang, Z. Y., San, H., Shu, H. B., Liptay, S., Gold, L., Gordon, D., & Derynck, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10759 · Cited by 380
Engelman, J. A., Wykoff, C. C., Yasuhara, S., Song, K. S., Okamoto, T., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16374 · Cited by 369
Takehara, K., LeRoy, E. C., & Grotendorst, G. R. (1987) · Cell · doi:10.1016/0092-8674(87)90294-7 · Cited by 347
Elevated expression of caveolin is associated with prostate and breast cancer.
Yang, G., Truong, L. D., Timme, T. L., Ren, C., Wheeler, T. M., Park, S. H., Nasu, Y., Bangma, C. H., Kattan, M. W., Scardino, P. T., et al. (1998) · PubMed · Cited by 331
Smad3 Mediates Transforming Growth Factor-β–Induced α-Smooth Muscle Actin Expression
Hu, B., Wu, Z., & Phan, S. H. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0063oc · Cited by 325
Inhibitory action of transforming growth factor beta on endothelial cells.
Müller, G., Behrens, J., Nussbaumer, U., Böhlen, P., & Birchmeier, W. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5600 · Cited by 323
Galbiati, F., Volonte', D., Liu, J., Capozza, F., Frank, P. G., Zhu, L., Pestell, R. G., & Lisanti, M. P. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2229 · Cited by 259
Isoforms of caveolin-1 and caveolar structure
Fujimoto, T., Kogo, H., Nomura, R., & Une, T. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.19.3509 · Cited by 252
Lino Cardenas, C. L., Henaoui, I. S., Courcot, E., Roderburg, C., Cauffiez, C., Aubert, S., Copin, M.-C., Wallaert, B., Glowacki, F., Dewaeles, E., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003291 · Cited by 251
Horowitz, J. C., Rogers, D. S., Sharma, V., Vittal, R., White, E. S., Cui, Z., & Thannickal, V. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.10.001 · Cited by 242
Self-citationHorowitz, J. C., Lee, D. Y., Waghray, M., Keshamouni, V. G., Thomas, P. E., Zhang, H., Cui, Z., & Thannickal, V. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306248200 · Cited by 239 · cited 9×
“Previous studies from our laboratory have also implicated early activation of the p38 MAPK pathway in the autocrine induction of growth factors that “protect”mesenchymal cells from serum deprivation-induced apoptosis [28].”
BackgroundMethodInfluentialSelf-citationHo, C.-C., Huang, P.-H., Huang, H.-Y., Chen, Y.-H., Yang, P.-C., & Hsu, S.-M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64442-2 · Cited by 228
Disorders of lung matrix remodeling
Chapman, H. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420729 · Cited by 224
Khalil, N., Xu, Y. D., O'Connor, R., & Duronio, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510441200 · Cited by 182
Capozza, F., Williams, T. M., Schubert, W., McClain, S. A., Bouzahzah, B., Sotgia, F., & Lisanti, M. P. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64335-0 · Cited by 179
Dual Role of Transforming Growth Factor β in Mammary Tumorigenesis and Metastatic Progression
Muraoka-Cook, R. S., Dumont, N., & Arteaga, C. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.937s.11.2 · Cited by 168
Sanders, Y. Y., Hagood, J. S., Liu, H., Zhang, W., Ambalavanan, N., & Thannickal, V. J. (2014) · European Respiratory Journal · doi:10.1183/09031936.00095113 · Cited by 167
Self-citationp42/44 MAP Kinase-dependent and -independent Signaling Pathways Regulate Caveolin-1 Gene Expression
Engelman, J. A., Zhang, X. L., Razani, B., Pestell, R. G., & Lisanti, M. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32333 · Cited by 165
Pathologic Caveolin-1 Regulation of PTEN in Idiopathic Pulmonary Fibrosis
Hong, X., Khalil, W., Kahm, J., Jessurun, J., Kleidon, J., & Henke, C. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091117 · Cited by 159
Qiu, P. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.09.002 · Cited by 143
Dai, C., Yang, J., & Liu, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300777200 · Cited by 143
Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation
Liu, J., Lee, P., Galbiati, F., Kitsis, R. N., & Lisanti, M. P. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.4.c823 · Cited by 139
Caveolin-1: a critical regulator of lung injury
Jin, Y., Lee, S.-J., Minshall, R. D., & Choi, A. M. K. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00170.2010 · Cited by 123
Prunier, C., & Howe, P. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500974200 · Cited by 120
Finlay, G. A., Thannickal, V. J., Fanburg, B. L., & Paulson, K. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000893200 · Cited by 105
Self-citationRegulation of human lung alveolar multipotent cells by a novel p38α MAPK/miR‐17‐92 axis
Oeztuerk-Winder, F., Guinot, A., Ochałek, A., & Ventura, J. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.192 · Cited by 93
Williams, T. M., Lee, H., Cheung, M. W.-C., Cohen, A. W., Razani, B., Iyengar, P., Scherer, P. E., Pestell, R. G., & Lisanti, M. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402064200 · Cited by 88
Nho, R. S., Peterson, M., Hergert, P., & Henke, C. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061017 · Cited by 82
Rosenbaum, J., Blazejewski, S., Préaux, A.-M., Mallat, A., Dhumeaux, D., & Mavier, P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90767-x · Cited by 78
Myofibroblasts: Molecular crossdressers
Walker, G. A., Guerrero, I. A., & Leinwand, L. A. (2001) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(01)51003-0 · Cited by 77
Cárcamo, J., Weis, F. M. B., Ventura, F., Wieser, R., Wrana, J. L., Attisano, L., & Massagué, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3810-3821.1994 · Cited by 71
Thannickal, V. J., Aldweib, K. D. L., Rajan, T., & Fanburg, B. L. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9443 · Cited by 61
Self-citationMutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
Chen, S.-T., Lin, S.-Y., Yeh, K.-T., Kuo, S., Chan, W.-L., Chu, Y.-P., & Chang, J. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.14.4.577 · Cited by 56
Boopathi, E., Gomes, C. M., Goldfarb, R., John, M., Srinivasan, V. G., Alanzi, J. A., Malkowicz, S. B., Kathuria, H., Zderic, S. A., Wein, A. J., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.038 · Cited by 38
Cited by
Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease
Gourdie, R. G., Dimmeler, S., & Kohl, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.89 · Cited by 332
Oxidative Stress in Pulmonary Fibrosis
Otoupalova, E., Smith, S., Cheng, G., & Thannickal, V. J. (2020) · Comprehensive Physiology · doi:10.1002/cphy.c190017 · Cited by 262
Self-citationUnraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Fibrostenotic strictures in Crohn’s disease
Yoo, J. H., Holubar, S. D., & Rieder, F. (2020) · Intestinal Research · doi:10.5217/ir.2019.09148 · Cited by 112
Fibroblast Senescence in Idiopathic Pulmonary Fibrosis
Lin, Y., & Xu, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.593283 · Cited by 115
Metadata
- Authors
- Sanders, Y. Y., Cui, Z., Le Saux, C. J., Horowitz, J. C., Rangarajan, S., Kurundkar, A., Antony, V. B., & Thannickal, V. J.
- Affiliations
- University of Alabama at Birmingham (US)
- University of Michigan (US)
- Corresponding author
- Thannickal, Victor J.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-02-06
- Volume
- 10
- Issue
- 2
- Pages
- e0116995
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4319960
- OpenAlex
- W2057677504
- Cited by
- 49
- References
- 58
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 14 · 2019: 4 · 2018: 5 · 2017: 6 · 2016: 3 · 2015: 1
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (HL114470)
- National Institute on Aging (R01AG046210)
- National Heart, Lung, and Blood Institute (P01HL114470, R01HL105489)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Keywords
- TGF-β1, caveolin-1, myofibroblast differentiation, Smad-independent signaling, p38 MAPK, lung fibroblasts, cell proliferation, apoptosis resistance, serum deprivation, fibrosis
- MeSH terms
- Cell Survival, Humans, MAP Kinase Signaling System, p38 Mitogen-Activated Protein Kinases, Cell Proliferation, Caveolin 1, Smad Proteins, Transforming Growth Factor beta1, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.